AU2011249487C1 - Organic peroxide compounds for microorganism inactivation - Google Patents

Organic peroxide compounds for microorganism inactivation Download PDF

Info

Publication number
AU2011249487C1
AU2011249487C1 AU2011249487A AU2011249487A AU2011249487C1 AU 2011249487 C1 AU2011249487 C1 AU 2011249487C1 AU 2011249487 A AU2011249487 A AU 2011249487A AU 2011249487 A AU2011249487 A AU 2011249487A AU 2011249487 C1 AU2011249487 C1 AU 2011249487C1
Authority
AU
Australia
Prior art keywords
inactivation
virus
organic peroxide
sample
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011249487A
Other languages
English (en)
Other versions
AU2011249487B2 (en
AU2011249487A1 (en
Inventor
Jens Peter Gregersen
Thomas Grudemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2011249487A1 publication Critical patent/AU2011249487A1/en
Application granted granted Critical
Publication of AU2011249487B2 publication Critical patent/AU2011249487B2/en
Publication of AU2011249487C1 publication Critical patent/AU2011249487C1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12061—Methods of inactivation or attenuation
    • C12N2720/12063—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16061—Methods of inactivation or attenuation
    • C12N2760/16063—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polymerization Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2011249487A 2010-05-06 2011-05-06 Organic peroxide compounds for microorganism inactivation Ceased AU2011249487C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39511710P 2010-05-06 2010-05-06
US61/395,117 2010-05-06
PCT/IB2011/001394 WO2011138682A2 (en) 2010-05-06 2011-05-06 Organic peroxide compounds for microorganism inactivation

Publications (3)

Publication Number Publication Date
AU2011249487A1 AU2011249487A1 (en) 2012-09-27
AU2011249487B2 AU2011249487B2 (en) 2014-10-02
AU2011249487C1 true AU2011249487C1 (en) 2015-05-14

Family

ID=44532956

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011249487A Ceased AU2011249487C1 (en) 2010-05-06 2011-05-06 Organic peroxide compounds for microorganism inactivation

Country Status (11)

Country Link
US (1) US9426989B2 (enExample)
EP (1) EP2566323A2 (enExample)
JP (1) JP6072677B2 (enExample)
KR (1) KR20130079398A (enExample)
CN (1) CN102946727B (enExample)
AU (1) AU2011249487C1 (enExample)
BR (1) BR112012028146A2 (enExample)
CA (1) CA2796213A1 (enExample)
EA (1) EA201291179A1 (enExample)
MX (1) MX343948B (enExample)
WO (1) WO2011138682A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883848B2 (en) 2011-07-14 2014-11-11 Ecolab Usa Inc. Enhanced microbial peracid compositions and methods of use at reduced temperatures in aseptic cleaning
US8906963B2 (en) 2011-07-14 2014-12-09 Ecolab Usa Inc Deodorization of peracids
GB2495341B (en) 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
ITUA20162517A1 (it) * 2016-04-12 2017-10-12 Andrea Fantozzi Composizione per la conservazione/fissazione di materiale biologico
WO2019086463A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN110804641A (zh) * 2019-09-04 2020-02-18 中国农业科学院兰州兽医研究所 一种比较分析不同牛支原体菌株毒力的方法
EP4054630A2 (en) 2019-11-07 2022-09-14 Seqirus UK Limited Compositions and methods for producing a viral vaccine with reduced particle size

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024304A1 (de) * 1979-08-18 1981-03-04 Hans-Dieter Dr. Deppe Vorrichtung zur Sterilisation von Matratzen und grossvolumigen Bett-Textilien
WO1997047708A1 (en) * 1996-06-08 1997-12-18 Oilfield Chemical Additives Ltd. Method of inhibiting reservoir souring by bacteria
WO2007042175A1 (en) * 2005-10-07 2007-04-19 Dsm Ip Assets B.V. Peroxide decomposition catalyst
US20070112062A1 (en) * 2003-04-16 2007-05-17 Luengo Alonso C Use of dialkylketone peroxide as biocidal, sterilizing, antiseptic, disinfecting and anti-parasitic agent
US20090186948A1 (en) * 2006-05-26 2009-07-23 Javier Chavez Inzunza Use of combinations of methyl ethyl ketone peroxide by spraying

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127618C (enExample) 1963-01-16
US3560395A (en) 1968-09-12 1971-02-02 Pennwalt Corp Aqueous ketone peroxide-hydrogen peroxide composition
US4060644A (en) * 1976-02-09 1977-11-29 Interox Chemicals Limited Bleaching
PH25669A (en) 1985-12-19 1991-09-04 Padmini Sampathkumar Anaerobe-selective antibacterial compositions, methods
EP0461700A1 (en) 1990-06-12 1991-12-18 Akzo Nobel N.V. Aqueous disinfectant compositions, and concentrates for preparing the same
US5437868A (en) 1991-07-23 1995-08-01 Ecolab Inc. Peroxyacid antimicrobial composition
GB9222561D0 (en) * 1992-10-27 1992-12-09 Ici Plc Macromolecular degradation
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
FR2738127B1 (fr) 1995-08-30 1998-03-27 Oreal Applicateur de mascara
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE19817743A1 (de) 1998-04-21 1999-10-28 Binker Materialschutz Gmbh Materialschutzmittel
AU758625B2 (en) 1998-08-20 2003-03-27 Ecolab Inc. The treatment of meat products
PL355287A1 (en) 1999-09-24 2004-04-05 Smithkline Beecham Biologicals S.A. Intranasal influenza virus vaccine
CA2401117C (en) 2000-03-03 2010-06-29 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
FR2808803B1 (fr) 2000-05-11 2004-12-10 Agronomique Inst Nat Rech Cellules es modifiees et gene specifique de cellules es
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
US20020107288A1 (en) 2000-12-08 2002-08-08 Singh Waheguru Pal Methods of sterilizing with dipercarboxylic acids
US7316824B2 (en) 2000-12-15 2008-01-08 Ecolab Inc. Method and composition for washing poultry during processing
EP1361890B1 (en) 2001-02-23 2011-03-30 GlaxoSmithKline Biologicals s.a. Influenza vaccine formulations for intradermal delivery
WO2002067983A1 (en) 2001-02-23 2002-09-06 Glaxosmithkline Biologicals S.A. Novel vaccine
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
US20030012804A1 (en) 2001-06-22 2003-01-16 Aquacide And Use Aquacide and use
JPWO2003014338A1 (ja) * 2001-08-02 2004-11-25 アンジェスＭｇ株式会社 不活性化ウイルスエンベロープの製造方法
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
DE10144903A1 (de) 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
FR2832423B1 (fr) 2001-11-22 2004-10-08 Vivalis Systeme d'expression de proteines exogenes dans un systeme aviaire
CN1194984C (zh) 2002-02-04 2005-03-30 中国农业科学院植物保护研究所 一种抗生素及其制备方法和应用
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
JP4299514B2 (ja) 2002-08-29 2009-07-22 長谷川香料株式会社 抗菌抗カビ剤
DE10306018A1 (de) * 2003-02-13 2004-09-09 Siemens Ag Analyse- und Diagnostikinstrument
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
AU2005245943A1 (en) 2004-05-20 2005-12-01 Id Biomedical Corporation Process for the production of an influenza vaccine
ES2526170T3 (es) 2004-12-23 2015-01-07 Medimmune, Llc Línea celular MDCK no tumorigénica para propagar virus
GB0505909D0 (en) 2005-03-23 2005-04-27 Univ Leeds Formulations
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
US8124397B2 (en) * 2005-08-08 2012-02-28 Oregon Health & Science University Inactivating pathogens with oxidizing agents for vaccine production
ATE494906T1 (de) 2005-11-01 2011-01-15 Novartis Vaccines & Diagnostic Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
JP2011506264A (ja) 2006-12-06 2011-03-03 ノバルティス アーゲー インフルエンザウイルスの４つの株に由来する抗原を含むワクチン

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024304A1 (de) * 1979-08-18 1981-03-04 Hans-Dieter Dr. Deppe Vorrichtung zur Sterilisation von Matratzen und grossvolumigen Bett-Textilien
WO1997047708A1 (en) * 1996-06-08 1997-12-18 Oilfield Chemical Additives Ltd. Method of inhibiting reservoir souring by bacteria
US20070112062A1 (en) * 2003-04-16 2007-05-17 Luengo Alonso C Use of dialkylketone peroxide as biocidal, sterilizing, antiseptic, disinfecting and anti-parasitic agent
WO2007042175A1 (en) * 2005-10-07 2007-04-19 Dsm Ip Assets B.V. Peroxide decomposition catalyst
US20090186948A1 (en) * 2006-05-26 2009-07-23 Javier Chavez Inzunza Use of combinations of methyl ethyl ketone peroxide by spraying

Also Published As

Publication number Publication date
EA201291179A1 (ru) 2013-04-30
BR112012028146A2 (pt) 2015-09-15
MX2012012335A (es) 2012-11-21
WO2011138682A2 (en) 2011-11-10
CA2796213A1 (en) 2011-11-10
KR20130079398A (ko) 2013-07-10
US9426989B2 (en) 2016-08-30
WO2011138682A3 (en) 2012-03-15
WO2011138682A8 (en) 2012-07-19
AU2011249487B2 (en) 2014-10-02
AU2011249487A1 (en) 2012-09-27
MX343948B (es) 2016-11-30
CN102946727B (zh) 2015-08-19
EP2566323A2 (en) 2013-03-13
CN102946727A (zh) 2013-02-27
US20130149194A1 (en) 2013-06-13
JP6072677B2 (ja) 2017-02-01
JP2013528586A (ja) 2013-07-11

Similar Documents

Publication Publication Date Title
US11466257B2 (en) Cell-derived viral vaccines with low levels of residual cell DNA
EP1789084B1 (en) Decreasing potential iatrogenic risks associated with influenza vaccines
AU2011249487B2 (en) Organic peroxide compounds for microorganism inactivation
HK1153955A (en) Cell-derived viral vaccines with low levels of residual cell dna
BRPI0618094B1 (pt) Método para preparar um produto de cultura de célula
HK1105364B (en) Decreasing potential iatrogenic risks associated with influenza vaccines
HK1144374B (en) Decreasing potential latrogenic risks associated with influenza vaccines

Legal Events

Date Code Title Description
MK24 Application lapsed reg. 22.2e(2) - failure to pay response fee
NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY THE EXAMINATION RESPONSE FEE HAS BEEN EXTENDED TO 13 DEC 2014 .

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 11 DEC 2014 .

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 11 DEC 2014

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired